The quality of life in diabetic hemodialysis patients
https://doi.org/10.24884/1561-6274-2019-23-4-80-87
Abstract
The aim: to compare the quality of life (QOL) in hemodialysis (HD) patients with diabetes and without it and to evaluate the impact of diabetes on QOL variables.
Patients and methods. 192 prevalent HD patients completed the Kidney Disease Quality of Life Short Form (KDQOL-SF™) questionnaire. Of these, 23 patients had diabetes.
Results. Compared with non-diabetic HD patients, HD patients with diabetes scored lower on physical component of QOL: the Physical functioning scale - 30.0 (10.0-45.0) vs 65.0 (40.0-80.0) (Me[IQR]), p<0.0001; Bodily pain - 45.0 (32.5-67.5) vs 57.5 (45.0-90.0), p=0.046; Physical Component Summary (PCS) - 25.4 (20.5-35.3) vs 36.6 (29.8-44.5), p<0.0001. In the presence of diabetes, the Odds Ratio (95% CI) of the Role Physical scale score being below 50 were 6.7 (1.5-29.6) times higher than in the absence of diabetes. The Vitality scale score was also lower in diabetic HD patients: 40.0 (25.0-45.0) vs 45.0 (35.0-60.0), p=0.006. Regarding the dialysis-specific scales, diabetic patients had poorer scores than non-diabetics on Symptoms/problems - 64.6 (58.3-70.8) vs 75.0 (62.5-85.4), p=0.012 and Sleep - 47.5 (35.0-62.5) vs 57.5 (45.0-72.5), p=0.012. In the presence of diabetes, the Odds Ratio (95% CI) of the Work status scale score being below 50 were 7.8 (1.8-34.3) times higher than in the absence of diabetes.
Conclusion. Diabetic HD patients scored significantly lower than non-diabetic on the scales of self-reported physical health, Vitality, Symptoms/problems, Sleep and Work status.
About the Authors
I. A. Vasilieva
Research Institute of Nephrology, Scientific and Clinical Research Centre, Pavlov First Saint-Petersburg State Medical University
Russian Federation
Russian Federation
Irina A. Vasilieva PhD, DPsycholSci, Laboratory of Renal Insufficiency, senior researcher.
197022, St-Petersburg, L. Tolstoy st., 17, build. 54, Phone (812) 338-69-34
R. V. Golubev
Research Institute of Nephrology, Scientific and Clinical Research Centre, Pavlov First Saint-Petersburg State Medical University
Russian Federation
Russian Federation
Roman V. Golubev - MD, PhD, Laboratory of Renal Insufficiency, head of laboratory.
197022, St-Petersburg, L. Tolstoy st., 17, build. 54, Phone (812) 338-69-34
A. N. Vasilyev
Research Institute of Nephrology, Scientific and Clinical Research Centre, Pavlov First Saint-Petersburg State Medical University
Russian Federation
Russian Federation
Alexander N. Vasilyev - MD, PhD, Department of Chronic Hemodialysis, head of department.
197022, St-Petersburg, L. Tolstoy st., 17, build. 54, Phone (812) 338-69-14
A. V. Smirnov
Research Institute of Nephrology, Scientific and Clinical Research Centre, Pavlov First Saint-Petersburg State Medical University
Russian Federation
Russian Federation
Alexey V. Smirnov - MD, PhD, DMedSci, Prof., director RINSCRC ; head of the department of propedeutics of internal diseases.
197022, St-Petersburg, L. Tolstoy st., 17, build. 54, Phone (812) 338-69-01
References
1. United States Renal Data System. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. https://www.usrds.org/adr.aspx
2. van den Brand JA. Diabetes mellitus as a cause of end-stage renal disease in Europe: signs of improvement. Clin Kidney J 2016; 9(3):454-456. Doi: 10.1093/ckj/sfw029
3. Yuan CM, Nee R, Ceckowski KA et al. Diabetic nephropathy as the cause of end-stage kidney disease reported on the medical evidence form CMS2728 at a single center. Clin Kidney J 2017; 10(2):257-262. Doi: 10.1093/ckj/sfw112
4. Burrows NR, Hora I, Geiss LS et al. Incidence of End-Stage Renal Disease attributed to diabetes among persons with diagnosed diabetes - United States and Puerto Rico, 2000-2014 MMWR Morb Mortal Wkly Rep 2017; 66(43):1165-1170. Doi: 10.15585/mmwr.mm6643a2
5. Rao A, Steenkamp R, Caskey F. UK Renal Registry 16th annual report: chapter 5 comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2011 to 2012. Nephron Clin Pract 2013; 125(1-4):99-110. Doi: 10.1159/000360024
6. Assogba FG, Couchoud C, Hannedouche T et al. French Renal Epidemiology and Information Network Registry. Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007-2011. Diabetologia 2014; 57(4):718-728. Doi: 10.1007/s00125-014-3160-9
7. Bikbov BT, Tomilina NA. The contingent and treatment quality indicators in patients on replacement therapy of end stage renal disease in the Russian Federation in 1998-2013 years. Nephrology and Dialysis 2016; 18 (2): 98-164 (in Russian)
8. Hays RD, Kallich J, Mapes DL et al. Kidney Disease Quality of Life Short Form (KDQOL-SF), Version 1.3: A Manual for Use and Scoring. RAND, P-7994, Santa Monica (CA), 1997; 1-39
9. Vasilieva IA. Validation of the Russian version of the Kidney Disease Quality of Life Short Form (KDQOL-SF™) Instrument. PRO Newsletter 2006; 36: 14-15
10. Ware JE, Kosinski M. SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1 (2nd Edition). QualityMetric Icorporated, Lincoln (RI), 2001; 1-237
11. Ware JEJr. SF-36 Health Survey Update. Spine (Phila Pa 1976) 2001; 25(24):3130-3139
12. Sorensen VR, Mathiesen ER, Watt T et al. Diabetic patients treated with dialysis: complications and quality of life. Diabetologia 2007; 50(11):2254-2262
13. Gumprecht J, Zelobowska K, Gosek K et al. Quality of life among diabetic and non-diabetic patients on maintenance haemodialysis. Exp Clin Endocrinol Diabetes 2010; 118(3):205-208. Doi: 10.1055/s-0029-1192023
14. Osthus TB, von der Lippe N, Ribu L et al. Health-related quality of life and all-cause mortality in patients with diabetes on dialysis. BMC Nephrol 2012; 13:78. Doi: 10.1186/1471-2369-13-78.
15. Hayashino X Fukuhara S, Akiba T et al. Low health-related quality of life is associated with all-cause mortality in patients with diabetes on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study. Diabet Med 2009; 26(9): 921-927. Doi: 10.1111/j.1464-5491.2009.02800.x
16. Fukuhara S, Lopes AA, Bragg-Gresham JL et al. Worldwide Dialysis Outcomes and Practice Patterns Study. Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003; 64(5):1903-1910
Review
For citations:
Vasilieva I.A., Golubev R.V., Vasilyev A.N., Smirnov A.V. The quality of life in diabetic hemodialysis patients. Nephrology (Saint-Petersburg). 2019;23(4):80-87. (In Russ.) https://doi.org/10.24884/1561-6274-2019-23-4-80-87
Views:
1772
Email this article 